So, it is no surprise that GLP1 analogs such as Ozempic and Wegovy work as weight-loss drugs
We provide a platform that connects you with licensed providers who understand these challenges
With adequate monitoring, your therapy will support your long-term wellness goals too
00:00:12 Narrator On this episode, associate editor and clinical pharmacist, Vicki Danaher, shares practical guidance on how Orforglopron, the second oral GLP-1 agonist for weight loss, stacks up against oral semaglutide in terms of dosing, efficacy, safety, cost, and more in an excerpt from our popular Pharmacy Essential Updates webinar series
District Judge Karen Marston, of the Eastern District of Pennsylvania, allowed some misrepresentation claims to go forward but tossed design defect and medical monitoring allegations
doi: 10.2337/DC06-2593 66